Acta Pharmaceutica · 2012 · 48 citations · 16 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryOral Drug DeliveryPharmaceutical FormulationEmulsion FormulationLipid-based Drug Delivery SystemsLipid-based Oral FormulationsOral Formulation DesignSelf-emulsifying Drug Delivery SystemsSurfactantsCharacterization Of Emulsion DropletsChemical Formulation DesignControlled Drug ReleaseDroplet Size DistributionEmulsificationEmulsification MechanismsOil Phase SelectionSurfactant Systems
Self-microemulsifying drug delivery system (SMEDDS) of lovastatin was aimed at overcoming the problems of poor solubility and bioavailability. The formulation strategy included selection of oil phase based on saturated solubility studies and surfactant and co-surfactant screening on the basis of their emulsification ability. Ternary phase diagrams were constructed to identify the self-emulsifying region. Capryol 90 (20%) as oil, Cremophore RH40 (40%) as surfactant and Transcutol P (40%) as co-surfactant were concluded to be optimized components. The prepared SMEDDS was characterized through its droplet size, zeta potential, emulsification time, rheological determination and transmission electron microscopy. The optimized formulation exhibited 94% in vitro drug release, which was significantly higher than that of the drug solution. In vivo studies using the Triton-induced hyperlipidemia model in Wistar rats revealed considerable reduction in lipid levels compared to pure lovastatin. The study confirmed the potential of lovastatin SMEDDS for oral administration.
16
Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems
Jing Cui, Bo Yu, Yu Zhao et al. · International Journal of Pharmaceutics · 2008 · 396 citations